Coccidioidomycosis Collaborative Research Centers — RFA-AI-27-012
Supports translational vaccine teams targeting valley fever through collaborative centers.
The National Institute of Allergy and Infectious Diseases (NIAID) issued RFA-AI-27-012 on May 4, 2026, to establish Coccidioidomycosis Collaborative Research Centers (CCRCs) — a new initiative funding highly collaborative, multi-disciplinary teams to conduct translational and clinical research in support of a Valley fever vaccine. Coccidioidomycosis, commonly called Valley fever, is a fungal infec…
Coccidioidomycosis (Valley fever) vaccine development — translational and clinical research aligned with NIAID's Strategic Plan.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline